PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:30 AM ET

Sponsor Check › Person

AL
No photo found yet (own website and image search run after this page is viewed)

Augustine Lawlor

Named as an officer, director or promoter on SEC Form D filings · CA, CO, NJ, MA, NM, Israel (as filed: L3) · Nov 24, 2009 → Mar 13, 2023

16deals (issuers)
$221.5Mreported sold
319investors
55Form D filings
2009–2023years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:02 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Augustine Lawlor is listed as an executive officer and director on 55 SEC Form D filings by 16 issuers between Dec 2008 and Mar 2023. Largest by amount reported sold: LEAP THERAPEUTICS, INC. (Cambridge, MA — pharmaceuticals — 2011–2023; $77.2M reported sold to 121 investors), CATALYST BIOSCIENCES INC (South San Fransicso, CA — biotechnology — 2008–2015; $40.4M reported sold to 21 investors), VAXINNATE CORP (Cranbury, NJ — biotechnology — 2009–2015; $24.8M reported sold to 14 investors), GLOBEIMMUNE INC (Louisville, CO — pharmaceuticals — 2009–2014; $18M reported sold to 110 investors), Pathogenetix, Inc. (Woburn, MA — industry reported as "Other" — 2010–2011; $11.5M reported sold to 8 investors) and 11 more (all listed below).

What this means That is a lot of deals — 16 separate companies raised money with this person listed as executive officer and director, over about 15 years. Across those companies the filings report $221.5M sold in total.

Listed alongside Ralph Christoffersen (21 shared filings), Nassim Usman (9 shared filings), Douglas E. Onsi (8 shared filings), Asish Xavier (7 shared filings), Christopher Mirabelli (7 shared filings) and 90 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Augustine. Each name links to their own page.

6 of the issuers belong to the sponsor group Healthcare (6 issuers, $81.2M reported sold, 2010–2023).

What this means A sponsor group is one team that sets up a new company for each deal. Healthcare has 6 companies on file and $81.2M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared the newest 50 of 55 public filings for Augustine Lawlor and found 19 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Augustine Lawlor appears on 7 deals that stopped filing before reaching their target; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Augustine Lawlor has not run yet — it is joining a line of 34,493 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:02 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Augustine Lawlor..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:02 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

19 differences found between the filings for Augustine Lawlor — 3 worth asking about (compared the newest 50 of 55 filings on Oct 24, 2026; older filings not covered)

Note · Feb 28, 2013 – Aug 25, 2016

Bankruptcy case: Christopher M. Mirabelli and Dana M. Mirabelli — filed Feb 28, 2013

United States Bankruptcy Court, D. New Jersey docket "Christopher M. Mirabelli and Dana M. Mirabelli" filed Feb 28, 2013, closed Aug 25, 2016. Christopher Mirabelli (listed on the same filings) is listed as Debtor ("Christopher M. Mirabelli and Dana M. Mirabelli"). Our match estimate: 80%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. New Jersey ↗Christopher Mirabelli — PartnerFacts page ↗
Sources
Worth asking · May 19, 2009 – Mar 19, 2010

Amount sold went down between filings — VAXINNATE CORP

The May 19, 2009 filing says $15,000,000 sold; the Mar 19, 2010 Form D says $5,207,792 sold — $9,792,208 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · May 19, 2009 ↗Form D (later) · Mar 19, 2010 ↗VAXINNATE CORP — PartnerFacts page ↗
Sources
Worth asking · Apr 27, 2010 – Jun 30, 2021

Augustine Lawlor appears on 7 deals that stopped filing before reaching their target

LayerBio, Inc. (last filing Jun 30, 2021; $205,000 sold of $1,000,000); GITR Inc. (last filing May 8, 2015; $3,250,000 sold of $18,500,000); Tensha Therapeutics, Inc. (last filing Aug 8, 2011; $500,000 sold of $15,000,000); Apofore Corp (last filing Aug 1, 2011; $500,000 sold of $10,000,000); Anexon, Inc. (last filing Oct 19, 2010; $3,000,000 sold of $12,000,001); Shape Pharmaceuticals, Inc. (last filing Oct 12, 2010; $2,000,000 sold of $4,500,000); and 1 more. Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

LayerBio, Inc. — PartnerFacts page ↗GITR Inc. — PartnerFacts page ↗Tensha Therapeutics, Inc. — PartnerFacts page ↗Apofore Corp — PartnerFacts page ↗
Sources
Worth asking · Dec 13, 2006 – Mar 13, 2023

9 Form Ds were filed more than 15 days after the first sale

Form D filed 120 days after the first sale — GLOBEIMMUNE INC · Form D filed 67 days after the first sale — Stemgent, Inc. · Form D filed 474 days after the first sale — Anexon, Inc. · Form D filed 1,406 days after the first sale — Anexon, Inc. · Form D filed 693 days after the first sale — Shape Pharmaceuticals, Inc. · and 4 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Mar 12, 2014 ↗GLOBEIMMUNE INC — PartnerFacts page ↗Form D · Aug 10, 2012 ↗Stemgent, Inc. — PartnerFacts page ↗
Sources
Note · May 5, 2009 – Jun 30, 2021

24 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — LayerBio, Inc. (latest filing Jun 30, 2021) · No amendment in the last 12 months on an offering that may still be open — VAXINNATE CORP (latest filing Sep 28, 2015) · No amendment in the last 12 months on an offering that may still be open — CATALYST BIOSCIENCES INC (latest filing Jul 13, 2015) · No amendment in the last 12 months on an offering that may still be open — GITR Inc. (latest filing May 8, 2015) · No amendment in the last 12 months on an offering that may still be open — CATALYST BIOSCIENCES INC (latest filing Feb 3, 2015) · and 19 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jun 30, 2021 ↗LayerBio, Inc. — PartnerFacts page ↗Form D · Sep 28, 2015 ↗VAXINNATE CORP — PartnerFacts page ↗
Sources
Note · Jan 7, 2011 – Nov 29, 2017

Augustine Lawlor's role changed at LEAP THERAPEUTICS, INC.: director → executive officer

The Jan 7, 2011 filing lists Augustine Lawlor as director; the Nov 29, 2017 Form D lists executive officer.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jan 7, 2011 ↗Form D · Nov 29, 2017 ↗Augustine Lawlor — PartnerFacts page ↗LEAP THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · May 19, 2009 – Jul 13, 2015

11 offerings changed their target amount between filings

Offering amount changed between filings — CATALYST BIOSCIENCES INC · Offering amount changed between filings — GITR Inc. · Offering amount changed between filings — GITR Inc. · Offering amount changed between filings — VAXINNATE CORP · Offering amount changed between filings — Pathogenetix, Inc. · and 6 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Jun 11, 2015 ↗Form D/A (later) · Jul 13, 2015 ↗CATALYST BIOSCIENCES INC — PartnerFacts page ↗Form D/A (earlier) · Jun 12, 2012 ↗
Sources
Note · Apr 8, 2011 – Feb 24, 2012

Minimum investment changed between filings — VAXINNATE CORP

The Apr 8, 2011 filing lists a minimum of $544; the Feb 24, 2012 Form D/A lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · Apr 8, 2011 ↗Form D/A (later) · Feb 24, 2012 ↗VAXINNATE CORP — PartnerFacts page ↗
Sources
Note · May 13, 2010 – Jun 10, 2011

Minimum investment changed between filings — Stemgent, Inc.

The May 13, 2010 filing lists a minimum of $500,000; the Jun 10, 2011 Form D/A lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · May 13, 2010 ↗Form D/A (later) · Jun 10, 2011 ↗Stemgent, Inc. — PartnerFacts page ↗
Sources
Note · Mar 19, 2010 – Feb 15, 2011

Minimum investment changed between filings — VAXINNATE CORP

The Mar 19, 2010 filing lists a minimum of $2,835; the Feb 15, 2011 Form D/A lists $544.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Mar 19, 2010 ↗Form D/A (later) · Feb 15, 2011 ↗VAXINNATE CORP — PartnerFacts page ↗
Sources
Note · May 19, 2009 – Mar 19, 2010

Minimum investment changed between filings — VAXINNATE CORP

The May 19, 2009 filing lists a minimum of $3,558; the Mar 19, 2010 Form D lists $2,835.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · May 19, 2009 ↗Form D (later) · Mar 19, 2010 ↗VAXINNATE CORP — PartnerFacts page ↗
Sources
Note · Mar 17, 2009 – Apr 27, 2010

Augustine Lawlor is written 2 different ways on the filings

listed as "Augustine Lawlor" on 49 filings (from Mar 17, 2009), and "Augustine J. Lawlor" on 4 filings (from Apr 27, 2010).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Mar 17, 2009 ↗Form D · Apr 27, 2010 ↗Augustine Lawlor — PartnerFacts page ↗
Sources
Note · Jan 7, 2011 – Mar 13, 2023

Industry group changed between filings — LEAP THERAPEUTICS, INC.

"Pharmaceuticals" (Jan 7, 2011); then "Biotechnology" (Nov 29, 2017); then "Pharmaceuticals" (Mar 13, 2023).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jan 7, 2011 ↗Form D · Nov 29, 2017 ↗Form D · Mar 13, 2023 ↗LEAP THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Jan 4, 2012 – May 8, 2015

Industry group changed between filings — GITR Inc.

"Pharmaceuticals" (Jan 4, 2012 to Dec 21, 2012); then "Biotechnology" (May 8, 2015).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jan 4, 2012 ↗Form D · May 8, 2015 ↗GITR Inc. — PartnerFacts page ↗
Sources
Note · Jul 22, 2011 – Jul 9, 2013

Reported revenue range changed between filings — NANOMR, INC.

"Decline to Disclose" (Jul 22, 2011); then "No Revenues" (Jul 9, 2013).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jul 22, 2011 ↗Form D · Jul 9, 2013 ↗NANOMR, INC. — PartnerFacts page ↗
Sources
Note · Dec 13, 2010 – Mar 12, 2013

Same name, different state: "Augustine Lawlor" (MN) is a separate record

This page covers filings where the address state is CA or CO or NJ or MA or NM or L3. A separate record, "Augustine Lawlor" with address state MN, is listed on 9 filings — most recently by Cardiovascular Systems Inc (Mar 12, 2013). Both records have filings in the same period (Dec 13, 2010 to Mar 12, 2013).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Augustine Lawlor (MN) — PartnerFacts page ↗Form D/A · Mar 12, 2013 ↗Cardiovascular Systems Inc — PartnerFacts page ↗Augustine Lawlor (CA,CO,NJ,MA,NM,L3) — this page ↗
Sources
Note · Jul 9, 2013 – Dec 20, 2013

Address moved from Salt Lake City, UT to Albuquerque, NM — NANOMR, INC.

The people listed on the Jul 9, 2013 filing give Salt Lake City, UT; on the Dec 20, 2013 filing they give Albuquerque, NM.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 9, 2013 ↗Form D · Dec 20, 2013 ↗NANOMR, INC. — PartnerFacts page ↗
Sources
Note · Jul 22, 2011 – Jul 9, 2013

Address moved from Albuquerque, NM to Salt Lake City, UT — NANOMR, INC.

The people listed on the Jul 22, 2011 filing give Albuquerque, NM; on the Jul 9, 2013 filing they give Salt Lake City, UT.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 22, 2011 ↗Form D · Jul 9, 2013 ↗NANOMR, INC. — PartnerFacts page ↗
Sources
Note · Mar 17, 2009 – Mar 13, 2023

Augustine Lawlor is listed with 6 different address states: CO, NJ, MA, NM, CA, L3

CO on 8 filings (Mar 17, 2009 to Jun 10, 2014); NJ on 1 filing (May 19, 2009); MA on 36 filings (Jan 19, 2010 to Mar 13, 2023); NM on 1 filing (Jul 22, 2011); CA on 6 filings (Sep 25, 2012 to Jul 13, 2015); Israel (as filed: L3) on 1 filing (Mar 19, 2021).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Mar 17, 2009 ↗Form D · May 19, 2009 ↗Form D · Jan 19, 2010 ↗Form D · Jul 22, 2011 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 55 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

4 of 41 offerings report sales commissions totalling $1,996,599; 0 report finder's fees; 2 report proceeds to related persons totalling $173,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 13, 2023 D
LEAP THERAPEUTICS, INC.
File 021-475708
$0$0$0None listed on this filingEDGAR ↗
Jun 30, 2021 D
LayerBio, Inc.
File 021-404810
$0$0$0None listed on this filingEDGAR ↗
Mar 19, 2021 D
PAINREFORM LTD.
File 021-392928
$389,999$0$0Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Nov 29, 2017 D
LEAP THERAPEUTICS, INC.
File 021-299736
$400,000$0$0NONE no CRD number reported
via Raymond James & Associates, Inc. (CRD 705 ↗)

NONE no CRD number reported
via Ladenburg Thalmann & Co. Inc. (CRD 505 ↗)
EDGAR ↗
Sep 28, 2015 D
VAXINNATE CORP
File 021-248311
$0$0$0None listed on this filingEDGAR ↗
Jul 13, 2015 D/A
CATALYST BIOSCIENCES INC
File 021-241558
$0$0$0None listed on this filingEDGAR ↗
May 8, 2015 D
GITR Inc.
File 021-239513
$0$0$0None listed on this filingEDGAR ↗
Feb 3, 2015 D
CATALYST BIOSCIENCES INC
File 021-233381
$0$0$0None listed on this filingEDGAR ↗
Oct 2, 2014 D
VAXINNATE CORP
File 021-225706
$0$0$0None listed on this filingEDGAR ↗
Jun 10, 2014 D/A
GLOBEIMMUNE INC
File 021-211908
$798,600 (est.)$0$0 (est.)Aegis Capital Corp. BrokerCheck CRD 15007 ↗
Kingsbury Capital LLC BrokerCheck CRD 147102 ↗		EDGAR ↗
Apr 23, 2014 D
CATALYST BIOSCIENCES INC
File 021-216115
$0$0$0None listed on this filingEDGAR ↗
Mar 12, 2014 D
GLOBEIMMUNE INC
File 021-213450
$0$0$0 (est.)None listed on this filingEDGAR ↗
Feb 10, 2014 D
Mosaic Biosciences, Inc.
File 021-211595
$0$0$0None listed on this filingEDGAR ↗
Dec 20, 2013 D
NANOMR, INC.
File 021-208520
$0$0$100,000 (est.)None listed on this filingEDGAR ↗
Aug 20, 2013 D
CATALYST BIOSCIENCES INC
File 021-201639
$0$0$0None listed on this filingEDGAR ↗
Jul 9, 2013 D
NANOMR, INC.
File 021-199233
$0$0$73,000 (est.)None listed on this filingEDGAR ↗
Dec 21, 2012 D/A
GITR Inc.
File 021-171111
$0$0$0None listed on this filingEDGAR ↗
Sep 25, 2012 D
CATALYST BIOSCIENCES INC
File 021-184613
$0$0$0None listed on this filingEDGAR ↗
Aug 10, 2012 D
Stemgent, Inc.
File 021-182570
$0$0$0None listed on this filingEDGAR ↗
Feb 24, 2012 D/A
VAXINNATE CORP
File 021-43952
$0$0$0 (est.)
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including director fees and/or executive officer salaries. The amounts of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Jan 31, 2012 D
Stemgent, Inc.
File 021-172717
$0$0$0None listed on this filingEDGAR ↗
Nov 4, 2011 D/A
Pathogenetix, Inc.
File 021-163699
$0$0$0None listed on this filingEDGAR ↗
Oct 28, 2011 D
Stemgent, Inc.
File 021-167970
$0$0$0None listed on this filingEDGAR ↗
Aug 8, 2011 D
Tensha Therapeutics, Inc.
File 021-164058
$0$0$0None listed on this filingEDGAR ↗
Aug 1, 2011 D
Apofore Corp
File 021-163739
$0$0$0None listed on this filingEDGAR ↗
Jul 22, 2011 D
NANOMR, INC.
File 021-163349
$0$0$0None listed on this filingEDGAR ↗
Jul 20, 2011 D
Mosaic Biosciences, Inc.
File 021-163239
$0$0$0None listed on this filingEDGAR ↗
Jun 10, 2011 D/A
Stemgent, Inc.
File 021-141981
$0$0$0 (est.)None listed on this filingEDGAR ↗
Apr 13, 2011 D
Stemgent, Inc.
File 021-158280
$0$0$0None listed on this filingEDGAR ↗
Jan 7, 2011 D
LEAP THERAPEUTICS, INC.
File 021-153226
$0$0$0None listed on this filingEDGAR ↗
Dec 13, 2010 D/A
Pathogenetix, Inc.
File 021-149968
$0$0$0None listed on this filingEDGAR ↗
Nov 3, 2010 D
Pathogenetix, Inc.
File 021-149969
$0$0$0None listed on this filingEDGAR ↗
Oct 19, 2010 D
Anexon, Inc.
File 021-149305
$0$0$0None listed on this filingEDGAR ↗
Oct 19, 2010 D
Anexon, Inc.
File 021-149306
$0$0$0None listed on this filingEDGAR ↗
Oct 12, 2010 D
Shape Pharmaceuticals, Inc.
File 021-148861
$0$0$0None listed on this filingEDGAR ↗
Oct 12, 2010 D
Shape Pharmaceuticals, Inc.
File 021-148863
$0$0$0None listed on this filingEDGAR ↗
Apr 27, 2010 D
HealthCare Ventures IX, L.P.
File 021-141176
$0$0$0 (est.)
The Issuer will pay HCV Management IX LLC, its Management Company, an annual management fee equal to a percentage of its committed capital or capital under management.
None listed on this filingEDGAR ↗
Feb 3, 2010 D/A
GLOBEIMMUNE INC
File 021-56316
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jan 19, 2010 D
Pathogenetix, Inc.
File 021-55322
$0$0$0None listed on this filingEDGAR ↗
Nov 24, 2009 D
Stemgent, Inc.
File 021-115615
$0$0$0 (est.)None listed on this filingEDGAR ↗
Dec 8, 2008 D
CATALYST BIOSCIENCES INC
File 021-60286
$408,000$0$0Seaview Securities LLC BrokerCheck CRD 126180 ↗EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 16

Every issuer that named Augustine Lawlor on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

LT
Pharmaceuticals · group: Healthcare

LEAP THERAPEUTICS, INC.

Cambridge, MA · Jan 7, 2011 → Mar 13, 2023 · 3 filings
  • Mar 13, 2023 · D · $77,219,193 sold of $77,219,193 · 121 investors · min. No minimum reported · role: Executive Officer (Mr. Lawlor is the Chief Operating Officer of the Issuer.) EDGAR ↗
  • Nov 29, 2017 · D · $18,000,001 sold of $18,000,001 · 14 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
  • Jan 7, 2011 · D · $9,930,400 sold of $30,500,000 · 4 investors · min. $2,930,400 · role: Director EDGAR ↗

Raised $77.2M from 121 investors (100% of the $77.2M target) as of the latest filing. Augustine is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

L
Biotechnology

LayerBio, Inc.

Lexington, MA · Jun 30, 2021
  • Jun 30, 2021 · D · $50,000 sold of $1,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $205K from 9 investors (21% of the $1M target) as of the latest filing. Augustine is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

P
Biotechnology

PAINREFORM LTD.

Tel Aviv, Israel (as filed: L3) · Mar 19, 2021
  • Mar 19, 2021 · D · $6,000,000 sold of $6,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6M from 3 investors (100% of the $6M target) as of the latest filing. Augustine is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VC
Biotechnology

VAXINNATE CORP

Cranbury, NJ · May 19, 2009 → Sep 28, 2015 · 7 filings
  • Sep 28, 2015 · D · $3,248,047 sold of $4,341,507 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 2, 2014 · D · $6,000,000 sold of $6,265,125 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 24, 2012 · D/A · $24,810,408 sold of $24,969,925 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 8, 2011 · D/A · $21,698,759 sold of $21,927,703 · 12 investors · min. $544 · role: Director EDGAR ↗
  • Feb 15, 2011 · D/A · $16,679,752 sold of $16,857,334 · 12 investors · min. $544 · role: Director EDGAR ↗
  • Mar 19, 2010 · D · $5,207,792 sold of $15,623,377 · 12 investors · min. $2,835 · role: Director EDGAR ↗
  • May 19, 2009 · D · $15,000,000 sold of $31,000,000 · 12 investors · min. $3,558 · role: Director EDGAR ↗

Raised $24.8M from 14 investors (100% of the $4.34M target) as of the latest filing. Augustine is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CB
Biotechnology

CATALYST BIOSCIENCES INC

South San Fransicso, CA · Dec 8, 2008 → Jul 13, 2015 · 7 filings
  • Jul 13, 2015 · D/A · $1,890,938 sold of $2,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 11, 2015 · D · $1,000,000 sold of $1,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 3, 2015 · D · $3,224,993 sold of $5,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 23, 2014 · D · $5,009,841 sold of $5,009,841 · 18 investors · min. $3,000 · role: Director EDGAR ↗
  • Aug 20, 2013 · D · $400,004 sold of $800,008 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 25, 2012 · D · $13,407,658 sold of $18,593,361 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 8, 2008 · D · $40,399,998 sold of $40,399,998 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $40.4M from 21 investors (100% of the $2M target) as of the latest filing. Augustine is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

G
Biotechnology

GITR Inc.

Cambridge, MA · Jan 4, 2012 → May 8, 2015 · 4 filings
  • May 8, 2015 · D · $1,500,000 sold of $18,500,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director (The President of the Issuer.) EDGAR ↗
  • Dec 21, 2012 · D/A · $3,250,000 sold of $6,500,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 12, 2012 · D/A · $2,250,000 sold of $2,750,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 4, 2012 · D · $1,250,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $3.25M from 1 investor (18% of the $18.5M target) as of the latest filing. Augustine is listed as executive officer, director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

G
Pharmaceuticals

GLOBEIMMUNE INC

Louisville, CO · Mar 17, 2009 → Jun 10, 2014 · 7 filings
  • Jun 10, 2014 · D/A · $7,500,000 sold of $7,500,000 · 110 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 12, 2014 · D · $391,730 sold of $391,730 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 13, 2014 · D · $7,500,000 sold of $7,500,000 · 92 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 3, 2010 · D/A · $17,999,124 sold of $17,999,124 · 27 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 27, 2010 · D · $17,507,816 sold of $17,999,124 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 20, 2009 · D · $13,000,000 sold of $13,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 17, 2009 · D · $2,564,710 sold of $5,000,000 · 17 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $18M from 110 investors (100% of the $7.5M target) as of the latest filing. Augustine is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MB
Biotechnology

Mosaic Biosciences, Inc.

Boulder, CO · Jul 20, 2011 → Feb 10, 2014 · 2 filings
  • Feb 10, 2014 · D · $2,274,000 sold of $2,310,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 20, 2011 · D · $1,030,462 sold of $1,030,462 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $11.4M from 7 investors (100% of the $2.31M target) as of the latest filing. Augustine is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

N
Biotechnology

NANOMR, INC.

Albuquerque, NM · Jul 22, 2011 → Dec 20, 2013 · 3 filings
  • Dec 20, 2013 · D · $2,400,000 sold of $2,400,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 9, 2013 · D · $2,623,512 sold of $2,623,512 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 22, 2011 · D · $11,430,685 sold of $17,930,685 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $11.4M from 8 investors (100% of the $2.4M target) as of the latest filing. Augustine is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Biotechnology

Stemgent, Inc.

Cambridge, MA · Nov 24, 2009 → Aug 10, 2012 · 7 filings
  • Aug 10, 2012 · D · $11,299,993 sold of $11,299,993 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 31, 2012 · D · $6,297,998 sold of $8,797,992 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 28, 2011 · D · $584,810 sold of $600,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 10, 2011 · D/A · $10,627,591 sold of $14,127,591 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 13, 2011 · D · $750,000 sold of $3,000,000 · 8 investors · min. $3,451 · role: Director EDGAR ↗
  • May 13, 2010 · D · $5,627,599 sold of $10,127,600 · 6 investors · min. $500,000 · role: Director EDGAR ↗
  • Nov 24, 2009 · D · $2,700,000 sold of $3,000,000 · 2 investors · min. $10,000 · role: Director EDGAR ↗

Raised $11.3M from 8 investors (100% of the $11.3M target) as of the latest filing. Augustine is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

P
Biotechnology

Pathogenetix, Inc.

Woburn, MA · Jan 19, 2010 → Nov 4, 2011 · 6 filings
  • Nov 4, 2011 · D/A · $11,499,996 sold of $11,500,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 29, 2011 · D · $3,999,996 sold of $9,500,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 13, 2010 · D/A · $1,510,453 sold of $1,810,453 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2010 · D · $900,000 sold of $1,200,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2010 · D · $1,310,453 sold of $1,310,453 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 19, 2010 · D · $1,000,000 sold of $2,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $11.5M from 8 investors (100% of the $11.5M target) as of the latest filing. Augustine is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

TT
Pharmaceuticals · group: Healthcare

Tensha Therapeutics, Inc.

Cambridge, MA · Aug 8, 2011
  • Aug 8, 2011 · D · $500,000 sold of $15,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $500K from 2 investors (3% of the $15M target) as of the latest filing. Augustine is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

AC
Pharmaceuticals · group: Healthcare

Apofore Corp

Cambridge, MA · Aug 1, 2011
  • Aug 1, 2011 · D · $500,000 sold of $10,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $500K from 2 investors (5% of the $10M target) as of the latest filing. Augustine is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

A
Biotechnology · group: Healthcare

Anexon, Inc.

Cambridge, MA · Oct 19, 2010 → Oct 19, 2010 · 2 filings
  • Oct 19, 2010 · D · $2,000,000 sold of $2,000,000 · 2 investors · min. $250,000 · role: Director EDGAR ↗
  • Oct 19, 2010 · D · $3,000,000 sold of $3,000,000 · 2 investors · min. $83,333 · role: Director EDGAR ↗

Raised $3M from 4 investors (100% of the $2M target) as of the latest filing. Augustine is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

SP
Pharmaceuticals · group: Healthcare

Shape Pharmaceuticals, Inc.

Cambridge, MA · Oct 12, 2010 → Oct 12, 2010 · 2 filings
  • Oct 12, 2010 · D · $1,000,000 sold of $4,500,000 · 1 investors · min. $400,000 · role: Director EDGAR ↗
  • Oct 12, 2010 · D · $2,000,000 sold of $2,000,000 · 1 investors · min. $2,000,000 · role: Director EDGAR ↗

Raised $2M from 1 investor (44% of the $4.5M target) as of the latest filing. Augustine is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

HV
Pooled Investment Fund · group: Healthcare

HealthCare Ventures IX, L.P.

Cambridge, MA · Apr 27, 2010
  • Apr 27, 2010 · D · $0 sold of $250,000,000 · 0 investors · min. $50,000 · role: Director EDGAR ↗

No sales reported yet as of the latest filing. Augustine is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Augustine Lawlor — MN, 1 issuer, Dec 13, 2010 → Mar 12, 2013 · no shared issuer

People around Augustine 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

HP
Management entity

HealthCare Partners IX, L.P.

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

HM
Management entity

HCV Management IX LLC

Director · 1 shared filing (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Ralph Christoffersen

Director · 21 shared filings (3 issuers) · also on 4 other issuers

Ralph Christoffersen is on 7 issuers in total — a repeat sponsor. Their page lists every one.

NU
No photo found yet (own website and image search run after this page is viewed)
Person

Nassim Usman

Executive Officer, Director · 9 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

DO
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas E. Onsi

Director, Executive Officer · 8 shared filings (5 issuers) · also on 3 other issuers

Douglas E. Onsi is on 8 issuers in total — a repeat sponsor. Their page lists every one.

AX
No photo found yet (own website and image search run after this page is viewed)
Person

Asish Xavier

Director · 7 shared filings (1 issuer) · also on 21 other issuers

Asish Xavier is on 22 issuers in total — a repeat sponsor. Their page lists every one.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Jeff Himawan

Director · 7 shared filings (1 issuer) · also on 5 other issuers

Jeff Himawan is on 6 issuers in total — a repeat sponsor. Their page lists every one.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

J. William Freytag

Director · 7 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Dan J Mitchell

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

TR
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy C Rodell

Executive Officer, Director · 7 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

PM
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Mieyal

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

HW
No photo found yet (own website and image search run after this page is viewed)
Person

Harold R. Werner

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

IR
No photo found yet (own website and image search run after this page is viewed)
Person

Ian Ratcliffe

Director, Executive Officer, Promoter · 7 shared filings (1 issuer) · also on 4 other issuers

Ian Ratcliffe is on 5 issuers in total — a repeat sponsor. Their page lists every one.

DW
No photo found yet (own website and image search run after this page is viewed)
Person

David Williams

Director · 7 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Mirabelli

Director, Executive Officer · 7 shared filings (4 issuers) · also on 7 other issuers

Christopher Mirabelli is on 11 issuers in total — a repeat sponsor. Their page lists every one.

EP
No photo found yet (own website and image search run after this page is viewed)
Person

Enrico Petrillo

Director · 6 shared filings (1 issuer) · also on 7 other issuers

Enrico Petrillo is on 8 issuers in total — a repeat sponsor. Their page lists every one.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Seth Rudnick

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

DAVID HOEY

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

JOHN J. CANEPA

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

Stefan Miltenyi

Director · 6 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

Philippe Chambon

Director · 6 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Alan R. Shaw

Director, Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew T. Drechsler

Executive Officer · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

STEPHEN GULLANS

Director · 5 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

SW
No photo found yet (own website and image search run after this page is viewed)
Person

Sam Wu

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Powell

Director · 5 shared filings (1 issuer) · also on 8 other issuers

Michael Powell is on 9 issuers in total — a repeat sponsor. Their page lists every one.

EG
No photo found yet (own website and image search run after this page is viewed)
Person

Ehud Geller

Director, Executive Officer · 5 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

HS
No photo found yet (own website and image search run after this page is viewed)
Person

Harold Selick

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Seth F. Berkley

Director · 4 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Steinberg

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Steinberg

Director, Executive Officer · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

John Frenz

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Darren Carroll

Director · 4 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

Jeff Rona

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David Apelian

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Burrill

Director · 3 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Bradner

Director · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

TH
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Hofstaetter

Executive Officer, Director, Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

VE
No photo found yet (own website and image search run after this page is viewed)
Person

Victor Esch

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Augustine Lawlor. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Sally Corning

Executive Officer, Director · 3 shared filings (1 issuer) · also on 9 other issuers

Sally Corning is on 10 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

H
Sponsor group

Healthcare

6 issuers · 11 filings · $81.2M reported sold · 2010–2023

One team, 6 deal companies. Augustine Lawlor is listed on 6 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Augustine Lawlor.

Same business address

30 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 16 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Augustine Lawlor by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 16 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Augustine Lawlor is listed on: none on file. No website or social profile named in CATALYST BIOSCIENCES INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #300,141 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (South San Fransicso, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Colorado state courts — find the court ↗New Jersey state courts — find the court ↗Massachusetts MassCourts ↗New Mexico state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Colorado Secretary of State business search ↗New Jersey Secretary of State business search ↗Massachusetts Secretary of State business search ↗New Mexico Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Augustine Lawlor appears on a new Form D, or when a court case or SEC action is matched to them. See plans →